206 related articles for article (PubMed ID: 31117948)
1. NeoPredPipe: high-throughput neoantigen prediction and recognition potential pipeline.
Schenck RO; Lakatos E; Gatenbee C; Graham TA; Anderson ARA
BMC Bioinformatics; 2019 May; 20(1):264. PubMed ID: 31117948
[TBL] [Abstract][Full Text] [Related]
2. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
[TBL] [Abstract][Full Text] [Related]
3. ScanNeo2: a comprehensive workflow for neoantigen detection and immunogenicity prediction from diverse genomic and transcriptomic alterations.
Schäfer RA; Guo Q; Yang R
Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37882750
[TBL] [Abstract][Full Text] [Related]
4. OpenVax: An Open-Source Computational Pipeline for Cancer Neoantigen Prediction.
Kodysh J; Rubinsteyn A
Methods Mol Biol; 2020; 2120():147-160. PubMed ID: 32124317
[TBL] [Abstract][Full Text] [Related]
5. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
[TBL] [Abstract][Full Text] [Related]
6. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
[TBL] [Abstract][Full Text] [Related]
7. CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens.
Bais P; Namburi S; Gatti DM; Zhang X; Chuang JH
Bioinformatics; 2017 Oct; 33(19):3110-3112. PubMed ID: 28605406
[TBL] [Abstract][Full Text] [Related]
8. INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery.
Zhang J; Mardis ER; Maher CA
Bioinformatics; 2017 Feb; 33(4):555-557. PubMed ID: 27797777
[TBL] [Abstract][Full Text] [Related]
9. In Silico Prediction of Tumor Neoantigens with TIminer.
Kirchmair A; Finotello F
Methods Mol Biol; 2020; 2120():129-145. PubMed ID: 32124316
[TBL] [Abstract][Full Text] [Related]
10. neoANT-HILL: an integrated tool for identification of potential neoantigens.
Coelho ACMF; Fonseca AL; Martins DL; Lins PBR; da Cunha LM; de Souza SJ
BMC Med Genomics; 2020 Feb; 13(1):30. PubMed ID: 32087727
[TBL] [Abstract][Full Text] [Related]
11. Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development.
Lancaster EM; Jablons D; Kratz JR
Genet Test Mol Biomarkers; 2020 Feb; 24(2):59-66. PubMed ID: 30907630
[TBL] [Abstract][Full Text] [Related]
12. Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy.
Nonomura C; Otsuka M; Kondou R; Iizuka A; Miyata H; Ashizawa T; Sakura N; Yoshikawa S; Kiyohara Y; Ohshima K; Urakami K; Nagashima T; Ohnami S; Kusuhara M; Mitsuya K; Hayashi N; Nakasu Y; Mochizuki T; Yamaguchi K; Akiyama Y
Immunol Lett; 2019 Apr; 208():52-59. PubMed ID: 30880120
[TBL] [Abstract][Full Text] [Related]
13. Best practices for bioinformatic characterization of neoantigens for clinical utility.
Richters MM; Xia H; Campbell KM; Gillanders WE; Griffith OL; Griffith M
Genome Med; 2019 Aug; 11(1):56. PubMed ID: 31462330
[TBL] [Abstract][Full Text] [Related]
14. The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity.
Wang Y; Xu J; Lan T; Zhou C; Liu P
Cancer Med; 2023 Dec; 12(24):21651-21665. PubMed ID: 37965778
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatic methods for cancer neoantigen prediction.
Boegel S; Castle JC; Kodysh J; O'Donnell T; Rubinsteyn A
Prog Mol Biol Transl Sci; 2019; 164():25-60. PubMed ID: 31383407
[TBL] [Abstract][Full Text] [Related]
16. Neoantigen Controversies.
Castro A; Zanetti M; Carter H
Annu Rev Biomed Data Sci; 2021 Jul; 4():227-253. PubMed ID: 34465181
[TBL] [Abstract][Full Text] [Related]
17. Neoantigen landscape in metastatic nasopharyngeal carcinoma.
Lin M; Zhang XL; You R; Yang Q; Zou X; Yu K; Liu YP; Zou RH; Hua YJ; Huang PY; Wang J; Zhao Q; Jiang XB; Tang J; Gu YK; Yu T; He GP; Xie YL; Wang ZQ; Liu T; Chen SY; Zuo ZX; Chen MY
Theranostics; 2021; 11(13):6427-6444. PubMed ID: 33995666
[No Abstract] [Full Text] [Related]
18. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment.
Newey A; Griffiths B; Michaux J; Pak HS; Stevenson BJ; Woolston A; Semiannikova M; Spain G; Barber LJ; Matthews N; Rao S; Watkins D; Chau I; Coukos G; Racle J; Gfeller D; Starling N; Cunningham D; Bassani-Sternberg M; Gerlinger M
J Immunother Cancer; 2019 Nov; 7(1):309. PubMed ID: 31735170
[TBL] [Abstract][Full Text] [Related]
19. ImmuneMirror: A machine learning-based integrative pipeline and web server for neoantigen prediction.
Chuwdhury GS; Guo Y; Chiang CL; Lam KO; Kam NW; Liu Z; Dai W
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38343325
[TBL] [Abstract][Full Text] [Related]
20. PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions.
Tan X; Xu L; Jian X; Ouyang J; Hu B; Yang X; Wang T; Xie L
Cells; 2023 Mar; 12(5):. PubMed ID: 36899918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]